Cytiva, a global life sciences leader, and NecstGen, have entered a strategic collaboration with the aim to accelerate the development of new cell and gene therapies globally. Cytiva will provide its technologies, services, and solutions to NecstGen, and both organizations will share their knowledge, expertise, and learnings as research programs are translated into next generation therapies.   Catarina Flyborg, vice president, Cell and Gene Therapy, Cytiva says: “Cell and gene therapies are tr...